Welcome To The BlockRx™ Token Sale

BlockRx

Category: blockchain

Hi, In this Ask the Experts, we take a fascinating departure from pharma supply chain and hear from Gary Ross, a partner at Ross and Shulga Law Firm. Mr. Ross is a business law attorney assisting VC/private equity funds, startups and other companies, and investors. He is particularly active in both the cryptocurrency and offshore…

Read More

Delegated Proof of Stake (DPoS) is a new consensus algorithm used to secure blockchain transactions and is an alternative to the Proof-of-Stake (PoS) and Proof-of-Work (PoW) models. Though PoW and PoS provide security, they require extensive resources, time and energy to process. However, the DPoS model eliminates these problems, as it is considered the fastest,…

Read More

Hi, In this Ask the Experts Segment, we had the pleasure to speak with David Houlding, Director of Healthcare Privacy and Security at Intel Health & Life Sciences. David brings more than 24 years of experience in healthcare, privacy, security, compliance, and more recently, blockchain, and artificial intelligence. David leads Intel Health & Life Sciences…

Read More

iSolve is aligning its vision of improving global health and safety by supporting several charities. Every token purchased by you will be matched by 2 tokens from iSolve’s founders and donated to our charity associations. The BlockRx project creates a decentralized system allowing drug manufacturers to trace pharmaceuticals across the entire supply chain, from manufacturer…

Read More

Hi, In this Ask the Experts Segment, we had the pleasure to speak with Marina Niforos, Founder at Logos Global Advisors, and an advisor to the International Finance corporation. Marina has over 20 years of experience in bridging the public and private sectors to provide solutions to complex competitiveness problems in a global context. She…

Read More

The BlockRx Project was mentioned in a publication from the International Finance Corporation, a member of the World Bank Group. The note, “Beyond Fintech: Leveraging Blockchain for More Sustainable and Inclusive Supply Chains investigates the non-FinTech implications of Blockchain Technology, including the Pharma supply chain, and it is part of a series of notes that…

Read More

The BlockRx Pharma Ecosystem ties together five subsystems which are involved in the pharmaceutical supply chain: Manufacturers, Distributors, Clinical Trials, Patients, and Regulators. The diagram below shows how the subsystems interact with each other through the Blockchain and ADLT™. So, what is each subsystem and how does it interact within the Ecosystem? Manufacturing – this…

Read More

     The management of Clinical Trial has so many different moving parts and participants that people often ask “How is Pharma ever going to improve the Clinical Trial process?”  Well, there are several challenges that are universal to all Clinical Trials.  For example:  Site Selection, Investigator Enrollment, Patient Enrollment, Data Management, Sites Advertising, etc….

Read More

A message from our Director of Pharmaceutical Solutions, Dr. Robert Panetta. The BlockRx Pharma Ecosystem Components: ADLT The BlockRx Pharma Ecosystem is built on three components: the Blockchain, the BlockRx Token, and the Advanced Digital Ledger Technology (ADLT™). The ADLT translates legacy data for the Blockchain, so Pharma can continue using their existing internal systems. It is…

Read More
Collecting and Protecting Patient Data

The goal of any clinical trial or post marketing surveillance effort (Phase IV studies) is to collect patient level data to evaluate a drug’s effectiveness while protecting the identity of the patient from those researcher evaluating the results of the trail. The challenge in this age of readily accessible personal data is to identify ways…

Read More

Watch for project updates on our Telegram Telegram Dismiss